GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects?

被引：22
|
作者：
Zweck, Elric [1 ,2 ,3 ]
Roden, Michael [1 ,2 ,4 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany
[2] German Ctr Diabet Res, Munich, Germany
[3] Heinrich Heine Univ, Fac Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany
[4] Heinrich Heine Univ, Fac Med, Div Endocrinol & Diabetol, Dusseldorf, Germany
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1016/S2213-8587(18)30351-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：89 / 90
页数：3
相关论文
共 50 条
  • [31] Emerging GLP-1 receptor agonists
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 607 - 618
  • [32] GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
    Ma, Xiaoxuan
    Liu, Zhenghong
    Ilyas, Iqra
    Little, Peter J.
    Kamato, Danielle
    Sahebka, Amirhossein
    Chen, Zhengfang
    Luo, Sihui
    Zheng, Xueying
    Weng, Jianping
    Xu, Suowen
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (08): : 2050 - 2068
  • [33] GLP-1 receptor agonists today
    Marre, Michel
    Penfornis, Alfred
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (03) : 317 - 327
  • [34] Positioning on GLP-1 receptor agonists
    Gimenez, Sergio
    Piskorz, Daniel
    Martinez Demaria, Diego
    Nanfara, Silvia
    Lorenzatti, Alberto
    Zapata, Gerardo
    Aguinaga Arrascue, Luis
    Perna, Eduardo
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2021, 50 : 4 - 10
  • [35] The Future of the GLP-1 Receptor Agonists
    Hirsch, Irl B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (15): : 1457 - 1458
  • [36] HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists?
    Mafham, Marion
    Preiss, David
    LANCET, 2018, 392 (10157): : 1489 - 1490
  • [37] GLP-1 receptor agonists: fighting obesity with an eye to cardiovascular risk
    Liuzzo, Giovanna
    Galiuto, Leonarda
    EUROPEAN HEART JOURNAL, 2021, 42 (17) : 1652 - 1653
  • [38] The effect of GLP-1 receptor agonists on targets for cardiovascular risk reduction
    Westrick, Christopher
    Snider, Melissa
    Arradaza, Nicole
    Sharma, Kavita
    PHARMACOTHERAPY, 2013, 33 (10): : E190 - E190
  • [39] GLP-1 receptor agonists and cardiovascular risk in routine clinical practice
    Schernthaner, Guntram
    Schernthaner-Reiter, Marie Helene
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (02): : 78 - 80
  • [40] GLP-1 Receptor Agonists and cardiovascular Outcomes: A Meta-analysis
    Chakaroun, R.
    DIABETOLOGE, 2018, 14 (02): : 104 - 106
12345